Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Roche NimbleGen Inc. logo — company profile

Roche NimbleGen Inc.

Founded 1999 558 employees Series F Total: $43.95M Biotechnology, Health Care +2

General Information

Company Name Roche NimbleGen Inc.
Founded Year 1999
Employees 558
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series F
Social

BounceWatch is an independent company data service, not affiliated with Roche NimbleGen Inc.. To contact Roche NimbleGen Inc., visit nimblegen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Roche NimbleGen Inc. compare?

A PDF of Roche NimbleGen Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Roche NimbleGen Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Roche NimbleGen Inc.

Roche NimbleGen is an innovator in the biotechnology and health care industries, founded in 1999. The company is renowned for its work in the life sciences market, collaborating closely with an integrated team of Roche Applied Science researchers worldwide. Based in Madison, WI, Roche NimbleGen is primarily focused on research activities and manufacturing target enrichment probe pools for DNA sequencing. The company leverages the efficiencies inherent in parallel enrichment, enabling researchers to design economical, high throughput, and time-saving next-generation sequencing experiments. Through its cutting-edge technology, Roche NimbleGen offers a clearer understanding of genomic structure and function, thereby shedding light on the impact of genes on biological processes. In December 6, 2005, the company secured a significant $8.20M Series F investment, underscoring its promise in the field of life science research and sequencing solutions.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series F $8.20M -
06 Dec 2005
Series F $12.75M 4
Baird Capital Topspin Partners Venture Investors
Baird Capital, Topspin Partners +2
02 Nov 2004
Series D $12.50M 6
Baird Capital Skyline Ventures State of Wisconsin Investment Board
Baird Capital, Skyline Ventures +4
17 Apr 2003
Series B $10.50M -
17 Oct 2001

Roche NimbleGen Inc. Alternatives & Competitors

View All Alternatives
Roche NimbleGen Inc. vs
Twist Bioscience
Twist Bioscience United States

Synthetic DNA for Health & Sustainability

IPO
1317 employees
Biotechnology, Health Care
Roche NimbleGen Inc. vs
JMDNA
JMDNA

JMDNA was founded in 2012 and headquartered in Shanghai, China. It is dedicated to providing the bes...

Series B
20 employees
Biotechnology, Health Care
Roche NimbleGen Inc. vs
WaferGen Biosystems
WaferGen Biosystems United States

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the lates...

Post-IPO Equity
21 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Roche NimbleGen Inc.

Roche NimbleGen is an innovator in the life sciences market, working with an integrated team among Roche Applied Science researchers worldwide. Our site in Madison, WI is focused on research activities and manufacturing target enrichment probe pools for DNA sequencing. Capitalizing on the efficienci...
Roche NimbleGen Inc. was founded in 1999.
Roche NimbleGen Inc. operates in Biotechnology, Health Care, Life Sciences and Marketing.
Roche NimbleGen Inc. has approximately 558 employees.
Roche NimbleGen Inc. has completed 4 funding rounds, raising a total of $43.95M. The latest funding stage is Series F.
Top alternatives and competitors to Roche NimbleGen Inc. include Twist Bioscience, JMDNA, WaferGen Biosystems, PrognomiQ Inc, Biognosys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Roche NimbleGen Inc. and Twist Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Roche NimbleGen Inc., https://bouncewatch.com/company/roche-nimblegen, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes